Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 646 AL 660

Unravelling neuronal death mechanisms: The role of cytokines and chemokines in immune imbalance in Alzheimer's disease progression

Kumari S, Dhapola R, Sharma P, Paidlewar M, Vellingiri B, Medhi B, HariKrishnaReddy D.

Ageing Res Rev. 2025 Dec;112:102883. doi: 10.1016/j.arr.2025.102883. Epub 2025 Aug 28.

[Insulin signaling and neuropathological changes in Alzheimer's disease]

Wakabayashi T.

Nihon Yakurigaku Zasshi. 2025;160(5):324-328. doi: 10.1254/fpj.25019.

The Therapeutic Potential of Flavonols in Alzheimer's Disease: Inhibiting Amyloid-β, Oxidative Stress, and Neuroinflammation

Zamanian MY, Khachatryan LG, Heidari M, Darabi R, Golmohammadi M, Al-Aouadi RFA, Akkol EK.

Biofactors. 2025 Sep-Oct;51(5):e70047. doi: 10.1002/biof.70047.

Harnessing nanoparticles for Alzheimer's disease: Innovations in drug delivery and pathology-specific treatments

Liu G, Sun Y.

J Alzheimers Dis. 2025 Oct;107(4):1374-1399. doi: 10.1177/13872877251374149. Epub 2025 Sep 3.

Therapeutic potential of small peptides in Alzheimer's disease: Advances in memory restoration and targeted delivery systems

Verma P, Khatun R, Jew KA, Prusty SK, Knafo S.

Neuropeptides. 2025 Dec;114:102559. doi: 10.1016/j.npep.2025.102559. Epub 2025 Sep 5.

Antibody Therapies for Alzheimer's Disease: A New Strategy for Targeted Therapy and Blood-Brain Barrier Delivery

Feng X, Wang H.

ACS Chem Neurosci. 2025 Sep 17;16(18):3450-3464. doi: 10.1021/acschemneuro.5c00484. Epub 2025 Sep 7.

A new lens on Alzheimer's disease: Insights into the Edinger-Westphal nucleus and its circuits

Zhou Y, Su T, Yuan M, Li WL, Zhou Y, Kou JX, Chang JS, Liu D, Chen L, Zhan K, Zhu LQ.

J Alzheimers Dis. 2025 Oct;107(4):1325-1339. doi: 10.1177/13872877251372587. Epub 2025 Sep 11.

Discovery of natural compounds and their derivatives against neuroinflammation: Pharmacological mechanisms and structure-activity relationship

Xin X, Zong T, Hu Z, Jin L, Zhou W, Sun J, Li G.

Bioorg Chem. 2025 Oct;165:108934. doi: 10.1016/j.bioorg.2025.108934. Epub 2025 Aug 30.

Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives

Hroudová J, Fišar Z.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Oct 2;142:111491. doi: 10.1016/j.pnpbp.2025.111491. Epub 2025 Sep 9.

Review of anti-amyloid-beta (Aβ) monoclonal antibodies for the treatment of Alzheimer's disease

Francis E, Paylor S, Van C, Mathews B, Sobhanian MJ, Mansour DZ, Hennawi G, Brandt NJ.

Expert Rev Clin Pharmacol. 2025 Dec;18(12):1063-1078. doi: 10.1080/17512433.2025.2556122. Epub 2025 Sep 22.

Navigation Between Alzheimer's Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology-Genetics and Neuroinflammation

Bowirrat A, Pinhasov A, Bowirrat A, Badgaiyan R.

Int J Mol Sci. 2025 Aug 26;26(17):8253. doi: 10.3390/ijms26178253.

Mast Cell Immunometabolism in Type 2 Diabetes and Alzheimer's Disease

Caslin HL, Kapadia M, Clemons TA.

J Cell Physiol. 2025 Sep;240(9):e70091. doi: 10.1002/jcp.70091.

Integrating molecular imaging with near-infrared theranostics to improve early detection and therapy of Alzheimer's disease

Mahajan G, Pandya K, Tripathi A, Kumar D.

Bioorg Chem. 2025 Oct;165:108949. doi: 10.1016/j.bioorg.2025.108949. Epub 2025 Sep 11.

Neutrophils and NETosis in Alzheimer's disease: Unraveling pathogenic mechanisms and novel therapeutic targets

Chavoshinezhad S, Beirami E, Izadpanah E.

Biomed Pharmacother. 2025 Nov;192:118568. doi: 10.1016/j.biopha.2025.118568. Epub 2025 Sep 18.

Animal models of tau propagation in Alzheimer's disease

Masuda-Suzukake M, Shimonaka S, Nonaka T, Hasegawa M.

Neurosci Res. 2025 Nov;220:104960. doi: 10.1016/j.neures.2025.104960. Epub 2025 Sep 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias